Overview

The Solid Tumor 1238 gene panel offers one of the widest genomic profiles available for solid tumors, and its clinical use depends on rigorous laboratory quality systems. This article reviews the accreditation, validation, and reporting standards behind the assay delivered by GIVE LIFE TIME International. Broad content demands stricter oversight because more findings must be interpreted responsibly.

How It Works

After validated extraction and capture-based library construction, sequencing runs are monitored with internal controls and reference samples to confirm sensitivity and specificity. Every report is released only after passing laboratory-defined quality thresholds and a dual review by qualified scientists. Deviations trigger automatic re-run rather than a qualified release.

Indications

The expanded panel supports comprehensive tumor profiling, hereditary cancer risk flags, and broad trial eligibility screening. It is suited to advanced cancers where maximum genomic information is expected to change management. Hereditary findings are reported with clear germline versus somatic labeling.

Specimen & Processing

Formalin-fixed paraffin-embedded tissue or extracted nucleic acid meeting the validated input range is required, with plasma accepted for cases where tissue is insufficient. Each sample is accessioned and barcoded to preserve identity through the workflow. A backup aliquot is stored for confirmatory testing. Sample identity is confirmed at every handoff, and residual material from the regulatory-focused workflow is retained for optional confirmatory re-analysis.

Storage & Sourcing

Reports are issued as a secure PDF through the portal within twelve to fourteen working days, with full sequence data archived. GIVE LIFE TIME International maintains the documentation and audit trail needed for regulated cross-border sample handling and recurring client audits. Client portals return multi-language reports for the Solid program and support bulk export to hospital information systems.

FAQ

Q: Under which quality standards is the 1238 panel performed? A: The assay runs under accredited laboratory procedures with documented standard operating procedures, proficiency testing, and traceable calibration materials. Records are retained for audit.

Q: How is analytical validation demonstrated? A: Sensitivity, specificity, and reproducibility are established against reference samples before release and re-confirmed through ongoing quality monitoring. Limits of detection are stated per gene.

Q: Are reports compatible with international clinic use? A: Reports follow a structured clinical format with terminology mapped to standard guidelines, supporting cross-border interpretation. Gene names use official symbols throughout.

Q: What documentation supports cross-border sample transfer? A: Chain-of-custody records, transport permits, and standardized requisition forms accompany every international shipment. Customs paperwork is prepared in advance to avoid delays.